Abstract 4142010: The Evolving Risk of Infective Endocarditis after Transcatheter Aortic Valve Replacement

Introduction Prosthetic valve endocarditis is a rare complication of aortic valve intervention, associated with high mortality and morbidity. There has been widespread growth in transcatheter aortic valve replacement (TAVR) use over the past decade including expansion to lower-risk and younger patients. Data on trends in incidence and outcomes of infective endocarditis (IE) after TAVR are sparse. Research Question With TAVR expansion, have there been any changes in the incidence of IE and 30-day surgical intervention and mortality, 2013-2022? Methods: Using Medicare data, we analyzed 280,073 TAVR patients. Joinpoint regression was used to evaluate IE incidence, reported as annual percent change (APC). Adjusted Cox models were used to evaluate associations between IE incidence and procedure year, patient characteristics, and 30-day outcomes. Results: IE incidence after TAVR decreased from 13.9/1000 person-years in 2013 to 10.6/1000 p-y in 2017 (APC=-7.7% [CI -12.2- -4.5%],p=0.01) and then was unchanged through 2022 (APC=0.9% [-0.3- 3.1%],p=0.23). Figure 1 depicts risk factors associated with post-TAVR IE. The reduction in non-elective procedures was associated with declining IE rates (p<0.001). After developing IE post TAVR, the 30-day risk-adjusted surgical intervention rate was 3.6% [3.1-4.1%]. In more recent years, patients were more likely to undergo such intervention within 30 days of IE diagnosis (sub-distribution HR (sHR):1.20 [1.12-1.29],p<0.001). Older IE patients (sHR:0.61[0.55-0.67],p<0.001), those on dialysis (sHR:0.48 [0.27-0.86],p=0.01) and those with permanent pacemakers (sHR:0.56 [0.34-0.93],p=0.03) were less likely to undergo intervention. The 30-day mortality risk of patient experiencing IE was 17.6% [16.8-18.5%] and remained similar across years. Conclusion: In Medicare patients, the adjusted risk of IE after TAVR declined over time, which may relate to increasing experience with TAVR, procedural technique, and declining rates of non-elective interventions. Patients with IE were more likely to undergo surgical intervention over time, especially younger and lower surgical risk patients. Mortality rates remained high and did not change, emphasizing the need for more research on management practices.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4142010
Primary Topic
Infective Endocarditis Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4142010: The Evolving Risk of Infective Endocarditis after Transcatheter Aortic Valve Replacement

Ranjit Deshpande, Alan J. Moskowitz, Torsten Doenst, Enoch Akowuah et al.
Circulation
Infective Endocarditis Diagnosis and Management
article

Abstract 4142010: The Evolving Risk of Infective Endocarditis after Transcatheter Aortic Valve Replacement

Ranjit Deshpande, Alan J. Moskowitz, Torsten Doenst, Enoch Akowuah, Shinobu Itagaki, Jo Chikwe, Sundos Alabbadi, Alexander Iribarne, Raj Makkar, W. Patricia Bandettini, Sabine Bleiziffer, Patrick T. O’Gara, Annetine C. Gelijns, Natalia Egorova, Shahab A. Akhter, Emilia Bagiella, Nana Toyoda, Josep Rodes-Cabau, Prof. Dr. med. Markus Krane
article en

Abstract

Introduction Prosthetic valve endocarditis is a rare complication of aortic valve intervention, associated with high mortality and morbidity. There has been widespread growth in transcatheter aortic valve replacement (TAVR) use over the past decade including expansion to lower-risk and younger patients. Data on trends in incidence and outcomes of infective endocarditis (IE) after TAVR are sparse. Research Question With TAVR expansion, have there been any changes in the incidence of IE and 30-day surgical intervention and mortality, 2013-2022? Methods: Using Medicare data, we analyzed 280,073 TAVR patients. Joinpoint regression was used to evaluate IE incidence, reported as annual percent change (APC). Adjusted Cox models were used to evaluate associations between IE incidence and procedure year, patient characteristics, and 30-day outcomes. Results: IE incidence after TAVR decreased from 13.9/1000 person-years in 2013 to 10.6/1000 p-y in 2017 (APC=-7.7% [CI -12.2- -4.5%],p=0.01) and then was unchanged through 2022 (APC=0.9% [-0.3- 3.1%],p=0.23). Figure 1 depicts risk factors associated with post-TAVR IE. The reduction in non-elective procedures was associated with declining IE rates (p<0.001). After developing IE post TAVR, the 30-day risk-adjusted surgical intervention rate was 3.6% [3.1-4.1%]. In more recent years, patients were more likely to undergo such intervention within 30 days of IE diagnosis (sub-distribution HR (sHR):1.20 [1.12-1.29],p<0.001). Older IE patients (sHR:0.61[0.55-0.67],p<0.001), those on dialysis (sHR:0.48 [0.27-0.86],p=0.01) and those with permanent pacemakers (sHR:0.56 [0.34-0.93],p=0.03) were less likely to undergo intervention. The 30-day mortality risk of patient experiencing IE was 17.6% [16.8-18.5%] and remained similar across years. Conclusion: In Medicare patients, the adjusted risk of IE after TAVR declined over time, which may relate to increasing experience with TAVR, procedural technique, and declining rates of non-elective interventions. Patients with IE were more likely to undergo surgical intervention over time, especially younger and lower surgical risk patients. Mortality rates remained high and did not change, emphasizing the need for more research on management practices.

CirculationVol. 150(Suppl_1)
Cedars-Sinai Medical Center (US), Brigham and Women's Hospital (US), Northwell Health (US), East Carolina University (US), Montreal Heart Institute (CA), Heart and Diabetes Center North Rhine-Westphalia (DE), Staten Island University Hospital (US), James Cook University Hospital (GB), South Tees Hospitals NHS Foundation Trust (GB), Yale University (US), Mount Sinai Medical Center (US), King's College Hospital NHS Foundation Trust (GB), Jena University Hospital (DE), Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Openalex Percentile: Top 69%
Infective Endocarditis Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.